European MH Group / General Genetic Theory & Techniques Television / North American MH Group / /
Continent
Europe / /
Country
New Zealand / /
Event
FDA Phase / /
Facility
Hospital MH Investigation Unit / Hospital Dr Mark Waddington / Royal Perth Hospital / /
IndustryTerm
energy balance / biotechnology / final gene product / /
MedicalCondition
specific MH myopathy / clinical headache / disease / Central Core Disease / floppy infant syndrome / myopathy / rare pharmacogenetic disorder / occult neuromuscular diseases / previously unrecognized specific myopathies / Porcine Stress Syndrome / Duchenne Muscular Dystrophy / myofibrillar necrosis / enzymatic dissociation / muscle hypotonia / contracture / related disorders / myopathies / severe muscular rigidity / be in diagnosing previously unrecognized specific myopathies / /
MedicalTreatment
gene therapy / /
Organization
Royal Perth Hospital MH Investigation Unit / West Australia Malignant Hyperthermia Investigation Unit / FANZCA Royal Perth Hospital / Royal Perth Hospital / /
Person
Mark Davis / Malignant Hyperthermia / Ording / Mark Waddington / /
Position
advocate / skilled laboratory scientist / Staff Anaesthetist / Acknowledgements The author / Paasuke RT / Brownell AK / representative / Staff Anaesthetist in Western Australia / /
Product
adenosine / halothane / RYR1 / MH / IVCT9 / /
ProvinceOrState
Western Australia / /
Region
West Australia / Australasia / Western Australia / /
Malignant Hyperthermia: Investigation for the Uninitiated MARK WADDINGTON, FANZCA Royal Perth Hospital Dr Mark Waddington is a Staff Anaesthetist at the Royal Perth Hospital in Western Australia. He first became interest